한글목차

혈액센터 및 병원 시장에 기회가 있는 세계 혈액성분채집술 시장의 미래는 유망합니다. 세계 혈액성분채집술 시장은 2025년부터 2031년까지 7.5%의 CAGR로 2031년까지 약 25억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 만성 신장 질환의 유병률 증가, 헌혈을 장려하는 정부 캠페인의 증가, 혈액 성분에 대한 수요 증가입니다.

• Lucintel의 예측에 따르면, 방법별로는 신선동결혈장, 충진 적혈구 등 혈액 성분의 제조에 널리 사용되는 원심분리가 예측 기간 동안 가장 큰 비중을 차지할 것으로 보입니다.
• 최종 용도별로는 예측 기간 동안 혈액 센터가 더 큰 부문을 차지할 것으로 예상됩니다.
• 지역별로는 북미가 최첨단 혈액성분채집술 시스템의 채택 증가와 이 지역 인구의 혈액 관련 질환 발병률 증가로 인해 예측 기간 동안 가장 큰 지역으로 남을 것으로 보입니다.

혈액성분채집술 시장의 전략적 성장 기회

혈액성분채집술 시장은 주요 응용 분야에서 몇 가지 전략적 성장 기회를 제공합니다. 이러한 기회는 기술 발전과 효과적인 치료에 대한 수요 증가로 인해 발생합니다.

• 종양 분야 : 암세포를 표적으로 하는 새로운 혈액성분채집술 요법이 유망한 결과를 보여줌에 따라 종양학 분야는 큰 성장 잠재력을 가지고 있습니다. 암 치료에서 혈액성분채집술의 활용이 확대되고 있습니다.
• 자가면역질환 치료 : 혈액성분채집술은 자가면역질환 치료에 점점 더 많이 사용되고 있으며, 환자의 예후를 개선하는 표적 치료제를 제공하고 있습니다. 이 용도는 시장의 주요 성장 분야입니다.
• 신흥시장 확대 : 신흥시장, 특히 아시아태평양 시장 진출은 의료 투자 증가와 환자 수 증가로 인해 큰 성장 기회를 제공합니다. 시장 진입 기업들은 이 지역으로의 진출에 집중하고 있습니다.
• 기술 혁신 : 자동화 시스템 및 필터 개선과 같은 새로운 혈액성분채집술 기술에 대한 투자는 치료 효율성과 환자 편의성을 향상시켜 성장 기회를 제공합니다. 기술 발전이 시장 성장의 원동력이 되고 있습니다.
• 규제 당국의 승인 및 지원 : 새로운 혈액성분채집술 기기 및 치료법에 대한 규제 당국의 승인은 혁신적인 솔루션의 도입을 촉진하고 시장 범위를 확대하여 성장 기회를 제공합니다.

이러한 전략적 성장 기회는 치료 용도 확대, 시장 범위 확대, 기술 혁신의 촉진으로 혈액성분채집술 시장을 발전시키고 있습니다. 기업들은 시장의 잠재력을 활용하기 위해 이러한 분야에 집중하고 있습니다.

혈액성분채집술 시장 촉진요인 및 과제

혈액성분채집술 시장은 성장을 형성하는 다양한 촉진요인 및 과제에 의해 영향을 받습니다. 기술 발전, 규제 요인, 경제 상황이 시장 역학에 중요한 역할을 합니다.

혈액성분채집술 시장을 견인하는 요인은 다음과 같습니다:

• 기술 발전 : 자동화 시스템 및 필터 개선 등 혈액성분채집술 기술의 혁신으로 치료의 정확성과 효율성이 향상되어 시장 성장을 촉진하고 있습니다.
• 채용 증가 : 암, 자가면역질환 등 다양한 치료용도로 혈액성분채집술의 채용이 증가하면서 시장 수요가 확대되고 있습니다.
• 규제 당국의 지원 : 새로운 혈액성분채집술 기기 및 치료법에 대한 규제 당국의 승인과 지원은 기술 혁신과 제품 도입을 촉진하고 시장 성장을 가속화하고 있습니다.
• 의료 투자 증가 : 특히 신흥 시장의 의료 인프라에 대한 투자 증가가 혈액성분채집술 서비스 및 기술 확장을 촉진하고 있습니다.
• 적용 분야 확대 : 다양한 의료 분야에서의 혈액성분채집술 활용 확대는 시장 성장과 혁신의 새로운 기회를 창출하고 있습니다.

혈액성분채집술 시장의 과제는 다음과 같습니다:

• 높은 비용 : 첨단 혈액성분채집술 기술 및 치료는 높은 비용으로 인해, 특히 개발도상국에서는 접근 및 도입이 제한될 수 있습니다.
• 규제적 장애물 : 새로운 혈액성분채집술 기기 및 치료법에 대한 복잡한 규제 요건에 대한 대응으로 인해 제품 승인 및 시장 진입이 지연될 수 있습니다.
• 제조의 복잡성 : 혈액성분채집술 장비 및 소모품의 제조가 복잡하기 때문에 생산 규모 확대 및 품질 유지에 어려움이 있습니다.

혈액성분채집술 시장은 기술 발전, 채택 증가, 규제 당국의 지원에 힘입어 성장하고 있지만, 높은 비용과 규제 장벽이라는 도전 과제에 직면해 있습니다. 시장의 성공을 위해서는 성장 촉진요인과 과제를 극복하는 것이 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 혈액성분채집술 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 혈액성분채집술 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 혈액성분채집술 시장 : 제품 종류별
  • 소모품·시약
  • 소프트웨어
  • 기기
• 세계의 혈액성분채집술 시장 : 방법별
  • 원심분리
  • 막분리
  • 선택 흡착
• 세계의 혈액성분채집술 시장 : 시술별
  • 기증/자동 혈액성분채집술
  • 치료용 혈액성분채집술
• 세계의 혈액성분채집술 시장 : 최종 용도별
  • 혈액 센터
  • 병원
  • 기타

제4장 지역별 시장 동향과 예측 분석(2019-2031년)

• 세계의 혈액성분채집술 시장 : 지역별
• 북미의 혈액성분채집술 시장
• 유럽의 혈액성분채집술 시장
• 아시아태평양의 혈액성분채집술 시장
• 기타 지역의 혈액성분채집술 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 혈액성분채집술 시장 성장 기회 : 제품 종류별
  • 세계의 혈액성분채집술 시장 성장 기회 : 방법별
  • 세계의 혈액성분채집술 시장 성장 기회 : 시술별
  • 세계의 혈액성분채집술 시장 성장 기회 : 최종 용도별
  • 세계의 혈액성분채집술 시장 성장 기회 : 지역별
• 세계의 혈액성분채집술 시장 최신 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 혈액성분채집술 시장 생산능력 확대
  • 세계의 혈액성분채집술 시장 기업 인수합병(M&A), 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

영문목차

The future of the global apheresis market looks promising with opportunities in the blood center and hospital markets. The global apheresis market is expected to reach an estimated $2.5 billion by 2031 with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

• Lucintel forecasts that, within the method category, the centrifugation segment will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.
• Within the end use category, blood centers will remain a larger segment over the forecast period.
• In terms of region, North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among the population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Apheresis Market

The apheresis market is influenced by several emerging trends that are transforming the industry. These trends reflect advancements in technology and shifts in treatment approaches, shaping the future of apheresis therapies.

• Technological Advancements: Innovations in apheresis technology, such as automated systems and improved filters, are enhancing treatment precision and patient comfort. These advancements are driving growth by making apheresis more efficient and accessible.
• Expansion in Therapeutic Applications: Apheresis is increasingly used for a wider range of conditions, including autoimmune diseases, cancer, and genetic disorders. This expansion is broadening the market and increasing demand for specialized apheresis therapies.
• Growth in Emerging Markets: Emerging markets, particularly in Asia-Pacific, are experiencing rapid growth in apheresis due to rising healthcare investments and increasing patient populations. This trend is opening new opportunities for market players in these regions.
• Integration of Data Analytics: The use of data analytics and AI in apheresis procedures is improving treatment outcomes and operational efficiency. These technologies are enabling more personalized and effective apheresis treatments.
• Regulatory Support and Approvals: Increasing regulatory approvals and support for new apheresis devices and therapies are accelerating market growth. Governments and health authorities are facilitating the introduction of innovative apheresis solutions.

These trends are reshaping the apheresis market by driving technological advancements, expanding therapeutic applications, and opening new growth opportunities. The focus on innovation and regulatory support is enhancing the effectiveness and reach of apheresis therapies.

Recent Developments in the Apheresis Market

Key developments in the apheresis market reflect technological advancements, regulatory changes, and increasing adoption across various therapeutic areas. These developments are driving growth and expanding the scope of apheresis treatments globally.

• Advanced Apheresis Technologies: New automated apheresis systems with enhanced precision and efficiency have been introduced, improving patient outcomes and treatment consistency. These innovations are setting new standards in the market.
• Regulatory Approvals for New Devices: Recent regulatory approvals for advanced apheresis devices have facilitated market expansion. These approvals are enabling the introduction of new technologies and expanding the range of available apheresis treatments.
• Increased Adoption in Oncology: The use of apheresis in oncology has increased, with new therapies targeting cancer cells showing promising results. This growth reflects a broader application of apheresis in cancer treatment.
• Expansion in Emerging Markets: The apheresis market is expanding rapidly in emerging markets due to increasing healthcare infrastructure and investments. This growth is opening new opportunities for market players and driving global market expansion.
• Innovative Therapeutic Applications: New therapeutic applications of apheresis are being explored, including treatments for autoimmune diseases and genetic disorders. These innovations are broadening the market and increasing demand for apheresis therapies.

These developments are significantly impacting the apheresis market by driving technological advancements, regulatory approvals, and expanding therapeutic applications. The market is growing rapidly due to these innovations and increasing global demand.

Strategic Growth Opportunities for Apheresis Market

The apheresis market offers several strategic growth opportunities across key applications. These opportunities are driven by advancements in technology and increasing demand for effective treatments.

• Oncology Applications: There is significant growth potential in oncology applications, with new apheresis therapies targeting cancer cells showing promising results. This opportunity is expanding the use of apheresis in cancer treatment.
• Autoimmune Disease Treatments: Apheresis is increasingly used for treating autoimmune diseases, providing targeted therapies that improve patient outcomes. This application is a key growth area in the market.
• Emerging Markets Expansion: Expanding into emerging markets, particularly in Asia-Pacific, offers substantial growth opportunities due to rising healthcare investments and increasing patient populations. Market players are focusing on these regions for expansion.
• Technological Innovations: Investing in new apheresis technologies, such as automated systems and improved filters, presents growth opportunities by enhancing treatment efficiency and patient comfort. Technological advancements are driving market growth.
• Regulatory Approvals and Support: Gaining regulatory approvals for new apheresis devices and therapies opens up growth opportunities by facilitating the introduction of innovative solutions and expanding market reach.

These strategic growth opportunities are driving the apheresis market forward by expanding therapeutic applications, increasing market reach, and fostering innovation. Companies are focusing on these areas to capitalize on market potential.

Apheresis Market Driver and Challenges

The apheresis market is influenced by various drivers and challenges that shape its growth. Technological advancements, regulatory factors, and economic conditions play key roles in market dynamics.

The factors responsible for driving the apheresis market include:

• Technological Advancements: Innovations in apheresis technology, including automated systems and improved filters, are enhancing treatment precision and efficiency, driving market growth.
• Increased Adoption: Growing adoption of apheresis for various therapeutic applications, including oncology and autoimmune diseases, is expanding market demand.
• Regulatory Support: Regulatory approvals and support for new apheresis devices and therapies are accelerating market growth by facilitating innovation and product introductions.
• Rising Healthcare Investments: Increased investments in healthcare infrastructure, particularly in emerging markets, are driving the expansion of apheresis services and technologies.
• Expanding Applications: The broadening use of apheresis in diverse medical fields is creating new opportunities for market growth and innovation.

Challenges in the apheresis market are:

• High Costs: The high cost of advanced apheresis technologies and treatments can limit accessibility and adoption, particularly in developing regions.
• Regulatory Hurdles: Navigating complex regulatory requirements for new apheresis devices and therapies can delay product approvals and market entry.
• Manufacturing Complexity: The complexity of manufacturing apheresis equipment and supplies can pose challenges in scaling up production and maintaining quality.

The apheresis market is driven by technological advancements, increased adoption, and regulatory support, but faces challenges such as high costs and regulatory hurdles. Addressing these challenges while capitalizing on growth drivers is crucial for market success.

List of Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the apheresis companies profiled in this report include-

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

Apheresis by Segment

The study includes a forecast for the global apheresis market by product type, method, procedure, end use, and region.

Apheresis Market by Product Type [Analysis by Value from 2019 to 2031]:

• Disposable and Reagents
• Software
• Devices

Apheresis Market by Method [Analysis by Value from 2019 to 2031]:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Apheresis Market by Procedure [Analysis by Value from 2019 to 2031]:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Apheresis Market by End Use [Analysis by Value from 2019 to 2031]:

• Blood Centers
• Hospitals
• Others

Apheresis Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Apheresis Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The below image highlights recent developments by major apheresis producers in key regions: the USA, China, India, Japan, and Germany

• United States: In the U.S., recent developments include the introduction of advanced apheresis technologies and increased adoption of automated systems. Regulatory approvals for new apheresis devices and therapies, particularly for oncology and autoimmune disorders, have accelerated market growth.
• China: China is witnessing significant growth in the apheresis market due to government initiatives supporting healthcare advancements. There is a rise in local manufacturing of apheresis equipment and an increase in clinical applications, particularly for treating blood disorders and cancer.
• Germany: Germany has seen advancements in apheresis technologies, with a focus on improving efficiency and patient comfort. The market is supported by strong healthcare infrastructure and research institutions developing new therapeutic applications for apheresis, especially in hematology and oncology.
• India: In India, the apheresis market is expanding due to increasing healthcare access and investments in medical technology. There is a growing focus on improving apheresis procedures for treating various diseases, supported by government health programs and private sector investments.
• Japan: The Japanese apheresis market is driven by technological innovations and a growing demand for advanced therapeutic solutions. The country is focusing on developing new apheresis technologies and expanding their use in treating chronic diseases and cancer.

Features of the Global Apheresis Market

Market Size Estimates: Apheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Apheresis market size by various segments, such as by product type, method, procedure, end use, and region in terms of value ($B).

Regional Analysis: Apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, methods, procedures, end uses, and regions for the apheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the apheresis market by product type (disposable and reagents, software, and devices), method (centrifugation, membrane separation, and selective adsorption), procedure (donor/automated apheresis and therapeutic apheresis), end use (blood centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Apheresis Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Apheresis Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Apheresis Market by Product Type
  • 3.3.1: Disposable and Reagents
  • 3.3.2: Software
  • 3.3.3: Devices
• 3.4: Global Apheresis Market by Method
  • 3.4.1: Centrifugation
  • 3.4.2: Membrane Separation
  • 3.4.3: Selective Adsorption
• 3.5: Global Apheresis Market by Procedure
  • 3.5.1: Donor/Automated Apheresis
  • 3.5.2: Therapeutic Apheresis
• 3.6: Global Apheresis Market by End Use
  • 3.6.1: Blood Centers
  • 3.6.2: Hospitals
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Apheresis Market by Region
• 4.2: North American Apheresis Market
  • 4.2.1: North American Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.2.2: North American Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.3: European Apheresis Market
  • 4.3.1: European Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.3.2: European Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.4: APAC Apheresis Market
  • 4.4.1: APAC Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.4.2: APAC Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.5: ROW Apheresis Market
  • 4.5.1: ROW Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.5.2: ROW Apheresis Market by End Use: Blood Centers, Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Apheresis Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Apheresis Market by Method
  • 6.1.3: Growth Opportunities for the Global Apheresis Market by Procedure
  • 6.1.4: Growth Opportunities for the Global Apheresis Market by End Use
  • 6.1.5: Growth Opportunities for the Global Apheresis Market by Region
• 6.2: Emerging Trends in the Global Apheresis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Apheresis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Apheresis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Kawasumi Laboratories
• 7.2: Nikkiso
• 7.3: Haemonetics Corporation
• 7.4: Asahi Kasei Medical
• 7.5: Cerus Corporation
• 7.6: Kaneka Corporation
• 7.7: Charles River Laboratories International
• 7.8: B. Braun Melsungen
• 7.9: Fresenius Kabi
• 7.10: Terumo BCT